stars 1 stars 2 stars 3

About CEPTYR: CEPTYR is the leading company in the field of protein tyrosine phosphatases (PTPs). CEPTYR uses its expertise in PTP science to develop and commercialize pharmaceuticals that improve the lives of cancer patients, and to collaborate with partners for medical applications in other diseases. It is collaborating with Eli Lilly and& Company for the discovery and development of PTP inhibitors to treat diabetes, obesity and impaired glucose tolerance. CEPTYR also has an active program to acquire pharmaceuticals at later various stages of development, such as those described in this release.

CEPTYR , Inc. Questions

The CEPTYR , Inc. annual revenue was $6.8 million in 2026.

CEPTYR , Inc. is based in Bothell, Washington.

The NAICS codes for CEPTYR , Inc. are [3254, 32541, 325, 32].

The SIC codes for CEPTYR , Inc. are [2834, 28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users